Stereotaxis, Inc. (Nasdaq: STXS) has completed the clinical trial required for FDA clearance of the Company's Vdrive Robotic Navigation System ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE